{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:30:02Z","timestamp":1794637802395,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Many copy number variants (CNVs) are implicated in neurodevelopmental disability, but exhibit incomplete penetrance. The definition of penetrance is often unclear. In published literature, penetrance typically includes the background risk of disease, while clinicians tend to exclude risks unrelated to the genetic variant. We propose a more clinically relevant definition of penetrance and develop a new formula for this. These changes are applied to existing data sources to produce updated penetrance estimates. Our findings indicate that most CNVs studied have significantly lower penetrance than previously published. Eleven CNVs, previously described as low-penetrant, are recalculated as having a penetrance close to 0% for intellectual disability. These include 1q21.1 proximal duplications [\n                    <jats:italic>RBM8A<\/jats:italic>\n                    ], 2q11.2 deletions [\n                    <jats:italic>TMEM127<\/jats:italic>\n                    ], 2q13 proximal deletions and duplications [\n                    <jats:italic>NPHP1<\/jats:italic>\n                    ], 6q16 duplications [\n                    <jats:italic>SIM1<\/jats:italic>\n                    ], 13q12 deletions [\n                    <jats:italic>CRYL1<\/jats:italic>\n                    ], 15q11.2 duplications [\n                    <jats:italic>NIPA1<\/jats:italic>\n                    ,\n                    <jats:italic>NIPA2<\/jats:italic>\n                    ], 15q13.3 duplications [\n                    <jats:italic>CHRNA7<\/jats:italic>\n                    ], 16p12.2 duplications [\n                    <jats:italic>CDR2<\/jats:italic>\n                    ], 16p13.11 duplications [\n                    <jats:italic>MYH11<\/jats:italic>\n                    ] and Xp22.3 duplications [\n                    <jats:italic>SHOX<\/jats:italic>\n                    ]. Previous estimates of CNV penetrance, which ranged from 10\u201340% have been recalculated as 1\u201310%. In conclusion, many previously published estimates of CNV penetrance are inflated. Re-evaluation of existing data reveals lower and more accurate penetrance estimates for intellectual disability. This has important implications for diagnosis, genetic counselling, and prenatal reporting of recurrent CNVs.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01948-0","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:14:41Z","timestamp":1760516081000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Updated penetrance estimates for recurrent copy number variants \u2013 an improved definition and formula"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1753-5872","authenticated-orcid":false,"given":"Shuxiang","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dudding-Byth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-6687","authenticated-orcid":false,"given":"Mark","family":"Pinese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-0024","authenticated-orcid":false,"given":"Edwin P.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"1948_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002579","volume":"12","author":"ED Carruth","year":"2019","unstructured":"Carruth ED, Young W, Beer D, James CA, Calkins H, Jing L, et al. Prevalence aNd Electronic Health Record-based Phenotype Of Loss-of-function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Genes. Circ Genom Precis Med. 2019;12:e002579.","journal-title":"Circ Genom Precis Med"},{"key":"1948_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329\u201333.","journal-title":"J Clin Oncol"},{"key":"1948_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","volume":"132","author":"DN Cooper","year":"2013","unstructured":"Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: Towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132:1077\u2013130.","journal-title":"Hum Genet"},{"key":"1948_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.biopsych.2013.07.022","volume":"75","author":"G Kirov","year":"2014","unstructured":"Kirov G, Rees E, Walters JT, Escott-Price V, Georgieva L, Richards AL, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2014;75:378\u201385.","journal-title":"Biol Psychiatry"},{"key":"1948_CR5","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/hmg\/ddq259","volume":"19","author":"Vassos","year":"2010","unstructured":"Vassos, Collier E, Holden DA, Patch S, Rujescu C, St D, et al. Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet. 2010;19:3477\u201381.","journal-title":"Hum Mol Genet"},{"key":"1948_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.119.043114","volume":"141","author":"JD Roberts","year":"2020","unstructured":"Roberts JD, Asaki SY, Mazzanti A, Bos JM, Tuleta I, Muir AR, et al. An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. Circulation. 2020;141:429\u201339.","journal-title":"Circulation"},{"key":"1948_CR7","first-page":"1","volume":"0","author":"L Allach El Khattabi","year":"2018","unstructured":"Allach El Khattabi L, Heide S, Caberg JH, Andrieux J, Doco Fenzy M, Vincent-Delorme C, et al. 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations. J Med Genet. 2018;0:1\u20137.","journal-title":"J Med Genet"},{"key":"1948_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/aur.1378","volume":"7","author":"P Chaste","year":"2014","unstructured":"Chaste P, Sanders SJ, Mohan KN, Klei L, Song Y, Murtha MT, et al. Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2. Autism Res. 2014;7:355\u201362.","journal-title":"Autism Res"},{"key":"1948_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmedgenet-2019-106448","volume":"57","author":"N Cosemans","year":"2020","unstructured":"Cosemans N, Vandenhove L, Vogels A, Devriendt K, Van Esch H, Van Buggenhout G, et al. The clinical relevance of intragenic NRXN1 deletions. J Med Genet. 2020;57:347\u201355.","journal-title":"J Med Genet"},{"key":"1948_CR10","doi-asserted-by":"publisher","first-page":"e1005993","DOI":"10.1371\/journal.pgen.1005993","volume":"12","author":"AR Isles","year":"2016","unstructured":"Isles AR, Ingason A, Lowther C, Walters J, Gawlick M, Stober G, et al. Parental Origin Of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia And Neurodevelopmental Disorders. PLoS Genet. 2016;12:e1005993.","journal-title":"PLoS Genet"},{"key":"1948_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1192\/bjp.2018.301","volume":"214","author":"KM Kendall","year":"2019","unstructured":"Kendall KM, Bracher-Smith M, Fitzpatrick H, Lynham A, Rees E, Escott-Price V, et al. Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank. Br J Psychiatry. 2019;214:297\u2013304.","journal-title":"Br J Psychiatry"},{"key":"1948_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm9082602","volume":"9","author":"I Maya","year":"2020","unstructured":"Maya I, Perlman S, Shohat M, Kahana S, YacobsonS, TenneT,et al. Should We Report 15q11.2 BP1-BP2 deletions and duplications in the prenatal setting?.J Clin Med.2020;9:11.","journal-title":"J Clin Med"},{"key":"1948_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s10038-018-0543-7","volume":"64","author":"KN Mohan","year":"2019","unstructured":"Mohan KN, Cao Y, Pham J, Cheung SW, Hoffner L, Ou ZZ, et al. Phenotypic association of 15q11.2 CNVs of the region of breakpoints 1-2 (BP1-BP2) in a large cohort of samples referred for genetic diagnosis. J Hum Genet. 2019;64:253\u20135.","journal-title":"J Hum Genet"},{"key":"1948_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/gim.2012.164","volume":"15","author":"JA Rosenfeld","year":"2013","unstructured":"Rosenfeld JA, Coe BP, Eichler EE, Cuckle H, Shaffer LG. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med. 2013;15:478\u201381.","journal-title":"Genet Med"},{"key":"1948_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/jmedgenet-2015-103621","volume":"53","author":"M Tropeano","year":"2016","unstructured":"Tropeano M, Howley D, Gazzellone MJ, Wilson CE, Ahn JW, Stavropoulos DJ, et al. Microduplications at the pseudoautosomal SHOX locus in autism spectrum disorders and related neurodevelopmental conditions. J Med Genet. 2016;53:536\u201347.","journal-title":"J Med Genet"},{"key":"1948_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejmg.2018.07.015","volume":"62","author":"Al","year":"2019","unstructured":"Al, Shehhi M, Forman EB, Fitzgerald JE, McInerney V, Krawczyk J, et al. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families. Eur J Med Genet. 2019;62:204\u20139.","journal-title":"Eur J Med Genet"},{"key":"1948_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/jmedgenet-2018-105879","volume":"56","author":"AE J\u00f8nch","year":"2019","unstructured":"J\u00f8nch AE, Douard E, Moreau C, Van Dijck A, Passeggeri M, Kooy F, et al. Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice. J Med Genet. 2019;56:701\u201310.","journal-title":"J Med Genet"},{"key":"1948_CR18","unstructured":"Unique. Rare Chromosome & Gene Disorder Guides: Rare Chromosome Disorder Support Group; 2024 Available from: https:\/\/rarechromo.org\/disorder-guides\/."},{"key":"1948_CR19","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2020.2159","volume":"77","author":"CL Martin","year":"2020","unstructured":"Martin CL, Wain KE, Oetjens MT, Tolwinski K, Palen E, Hare-Harris A, et al. Identification of neuropsychiatric copy number variants in a health care system population. JAMA Psychiatry. 2020;77:1276\u201385.","journal-title":"JAMA Psychiatry"},{"key":"1948_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ridd.2010.12.018","volume":"32","author":"PK Maulik","year":"2011","unstructured":"Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 2011;32:419\u201336.","journal-title":"Res Dev Disabil"},{"key":"1948_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101227","volume":"27","author":"S Goh","year":"2025","unstructured":"Goh S, Thiyagarajan L, Dudding-Byth T, Pinese M, Kirk EP. A systematic review and pooled analysis of penetrance estimates of copy-number variants associated with neurodevelopment. Genet Med. 2025;27:101227.","journal-title":"Genet Med."},{"key":"1948_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-38","volume":"9","author":"BW van Paassen","year":"2014","unstructured":"van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. Orphanet J Rare Dis. 2014;9:38.","journal-title":"Orphanet J Rare Dis"},{"key":"1948_CR23","unstructured":"Chrestian N Hereditary Neuropathy with Liability to Pressure Palsies. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews(\u00ae). Seattle (WA) 1993."},{"key":"1948_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/gim.2013.16","volume":"15","author":"PA Benn","year":"2013","unstructured":"Benn PA. Prenatal counseling and the detection of copy-number variants. Genet Med. 2013;15:316\u20137.","journal-title":"Genet Med"},{"key":"1948_CR25","volume":"5","author":"LM Schultz","year":"2024","unstructured":"Schultz LM, Knighton A, Huguet G, Saci Z, Jean-Louis M, Mollon J, et al. Copy-number variants differ in frequency across genetic ancestry groups. HGG Adv. 2024;5:100340.","journal-title":"HGG Adv"},{"key":"1948_CR26","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/pd.5373","volume":"38","author":"J Muys","year":"2018","unstructured":"Muys J, Blaumeiser B, Jacquemyn Y, Bandelier C, Brison N, Bulk S, et al. The Belgian MicroArray Prenatal (BEMAPRE) database: A systematic nationwide repository of fetal genomic aberrations. Prenat Diagn. 2018;38:1120\u20138.","journal-title":"Prenat Diagn"},{"key":"1948_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ajmg.b.32439","volume":"171","author":"D Zhou","year":"2016","unstructured":"Zhou D, Gochman P, Broadnax DD, Rapoport JL, Ahn K. 15q13.3 duplication in two patients with childhood-onset schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2016;171:777\u201383.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1948_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bcp.2015.06.012","volume":"97","author":"MA Gillentine","year":"2015","unstructured":"Gillentine MA, Schaaf CP. The human clinical phenotypes of altered CHRNA7 copy number. Biochem Pharmacol. 2015;97:352\u201362.","journal-title":"Biochem Pharmacol"},{"key":"1948_CR29","unstructured":"ClinGen. 15q13.3 recurrent region (D-CHRNA7 to BP5) (includes CHRNA7 and OTUD7A): ClinGen Dosage Sensitivity Curation Page; 2018 [updated 10\/5\/2018. Available from: https:\/\/dosage.clinicalgenome.org\/clingen_region.cgi?id=ISCA-46295."},{"key":"1948_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-05267-w","volume":"22","author":"M Cai","year":"2022","unstructured":"Cai M, Que Y, Chen X, Chen Y, Liang B, Huang H, et al. 16p13.11 microdeletion\/microduplication in fetuses: investigation of associated ultrasound phenotypes, genetic anomalies, and pregnancy outcome follow-up. BMC Pregnancy Childbirth. 2022;22:913.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1948_CR31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/pd.5751","volume":"40","author":"J Muys","year":"2020","unstructured":"Muys J, Jacquemyn Y, Blaumeiser B, Bourlard L, Brison N, Bulk S, et al. Prenatally detected copy number variants in a national cohort: A postnatal follow-up study. Prenat Diagn. 2020;40:1272\u201383.","journal-title":"Prenat Diagn"},{"key":"1948_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41431-020-00707-7","volume":"29","author":"D Smajlagi\u0107","year":"2021","unstructured":"Smajlagi\u0107 D, Lavrichenko K, Berland S, Helgeland \u00d8, Knudsen GP, Vaudel M, et al. Population prevalence and inheritance pattern of recurrent CNVs associated with neurodevelopmental disorders in 12,252 newborns and their parents. Eur J Hum Genet. 2021;29:205\u201315.","journal-title":"Eur J Hum Genet"},{"key":"1948_CR33","unstructured":"Fu J, Liao C, Collins R, Wang L, Ben-Isvy D, Brand H, et al. Rare coding CNVs from exome sequenced individuals in gnomAD v4 GnomAD: GnomAD; 2023 [updated 1\/11\/2023. Available from: https:\/\/gnomad.broadinstitute.org\/news\/2023-11-v4-copy-number-variants\/."},{"key":"1948_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41588-023-01449-0","volume":"55","author":"M Babadi","year":"2023","unstructured":"Babadi M, Fu JM, Lee SK, Smirnov AN, Gauthier LD, Walker M, et al. GATK-gCNV enables the discovery of rare copy number variants from exome sequencing data. Nat Genet. 2023;55:1589\u201397.","journal-title":"Nat Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01948-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01948-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01948-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:45:59Z","timestamp":1789728359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01948-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01948-0","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All data used in this study is publicly available. There are no other relevant ethical declarations.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}